SI4070788T1 - Farmacevtske formulacije - Google Patents

Farmacevtske formulacije

Info

Publication number
SI4070788T1
SI4070788T1 SI201631702T SI201631702T SI4070788T1 SI 4070788 T1 SI4070788 T1 SI 4070788T1 SI 201631702 T SI201631702 T SI 201631702T SI 201631702 T SI201631702 T SI 201631702T SI 4070788 T1 SI4070788 T1 SI 4070788T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
SI201631702T
Other languages
English (en)
Inventor
Joanna M. Koziara
Scott Mccallister
Original Assignee
Gilead Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56418608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI4070788(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Sciences, Inc. filed Critical Gilead Sciences, Inc.
Publication of SI4070788T1 publication Critical patent/SI4070788T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SI201631702T 2015-06-30 2016-06-29 Farmacevtske formulacije SI4070788T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562187113P 2015-06-30 2015-06-30
US201662298373P 2016-02-22 2016-02-22
US201662301429P 2016-02-29 2016-02-29
US201662317286P 2016-04-01 2016-04-01
EP22176537.3A EP4070788B1 (en) 2015-06-30 2016-06-29 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
SI4070788T1 true SI4070788T1 (sl) 2023-06-30

Family

ID=56418608

Family Applications (4)

Application Number Title Priority Date Filing Date
SI201631707T SI4070787T1 (sl) 2015-06-30 2016-06-29 Farmacevtske formulacije
SI201631582T SI3607939T1 (sl) 2015-06-30 2016-06-29 Farmacevtske formulacije, ki obsegajo tenofovir in emtricitabin
SI201631702T SI4070788T1 (sl) 2015-06-30 2016-06-29 Farmacevtske formulacije
SI201630656T SI3316868T1 (sl) 2015-06-30 2016-06-29 Farmacevtske formulacije, ki vsebujejo tenofovir in emtricitabin

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SI201631707T SI4070787T1 (sl) 2015-06-30 2016-06-29 Farmacevtske formulacije
SI201631582T SI3607939T1 (sl) 2015-06-30 2016-06-29 Farmacevtske formulacije, ki obsegajo tenofovir in emtricitabin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI201630656T SI3316868T1 (sl) 2015-06-30 2016-06-29 Farmacevtske formulacije, ki vsebujejo tenofovir in emtricitabin

Country Status (26)

Country Link
US (2) US20170000807A1 (sl)
EP (5) EP4070787B1 (sl)
JP (3) JP6667556B2 (sl)
KR (2) KR102121329B1 (sl)
CN (1) CN107847450A (sl)
AU (3) AU2016287500B2 (sl)
BR (1) BR112017027843A2 (sl)
CA (1) CA2990210C (sl)
CL (1) CL2017003320A1 (sl)
CO (1) CO2017013293A2 (sl)
CU (1) CU20170168A7 (sl)
DO (1) DOP2017000306A (sl)
EA (1) EA201792592A1 (sl)
EC (1) ECSP17084331A (sl)
ES (4) ES2925246T3 (sl)
HK (1) HK1248547A1 (sl)
IL (1) IL256364A (sl)
MA (1) MA50541A (sl)
MX (1) MX2017016806A (sl)
PE (1) PE20180411A1 (sl)
PH (1) PH12017502431A1 (sl)
PL (4) PL3607939T3 (sl)
PT (4) PT4070788T (sl)
SI (4) SI4070787T1 (sl)
SV (1) SV2017005601A (sl)
WO (1) WO2017004244A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12019501848A1 (en) 2012-12-21 2020-03-02 Gilead Sciences Inc Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
ES2892123T3 (es) 2014-12-26 2022-02-02 Univ Emory Derivados antivíricos de N4-hidroxicitidina
ES2757560T3 (es) 2015-11-09 2020-04-29 Gilead Sciences Inc Composiciones terapéuticas para el tratamiento del virus de la inmunodeficiencia humana
BR112019016935A2 (pt) 2017-02-17 2020-04-07 Eidos Therapeutics Inc processos para preparação de ag-10, seus intermediários e sais dos mesmos
WO2018153977A1 (en) * 2017-02-24 2018-08-30 Hexal Ag Stable composition of tenofovir alafenamide
US11191763B2 (en) 2017-03-20 2021-12-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services HIV post-exposure prophylaxis
RU2662160C9 (ru) * 2017-07-03 2018-10-22 Александрович Иващенко Андрей Комбинированный лекарственный препарат для терапии вирусных инфекций
WO2019113462A1 (en) 2017-12-07 2019-06-13 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
MX2020009844A (es) 2018-03-23 2021-01-15 Eidos Therapeutics Inc Metodos para tratar amiloidosis por transtiretina (ttr) usando ag10.
US11260047B2 (en) 2018-08-17 2022-03-01 Eidos Therapeutics, Inc. Formulations of AG10
CN111096954B (zh) * 2018-10-29 2022-09-16 江苏豪森药业集团有限公司 一种用于抗病毒感染的药物组合物及制备方法
CN110251476B (zh) * 2019-08-01 2022-08-09 海思科制药(眉山)有限公司 一种恩曲他滨替诺福韦药物组合物
CN110917197A (zh) * 2019-12-31 2020-03-27 常州恒邦药业有限公司 一种替诺福韦酯与恩曲他滨的药物组合物及其制备方法
TWI728709B (zh) * 2020-02-19 2021-05-21 台灣森本生物科技開發股份有限公司 含有得自於藤黃樹脂的丙酮萃取產物的藥學組成物以及由該組成物所製得的配方
CN117338733B (zh) * 2023-10-12 2024-05-28 杭州和泽坤元药业有限公司 一种富马酸替诺福韦二吡呋酯片及其制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3235823A1 (en) 2000-07-21 2017-10-25 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
DK1583542T3 (da) 2003-01-14 2008-09-22 Gilead Sciences Inc Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) * 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
CA2750521A1 (en) 2009-02-06 2010-08-12 Gilead Sciences, Inc. Tablets for combination therapy
TWI516499B (zh) 2011-08-16 2016-01-11 吉李德科學股份有限公司 泰諾福韋（ｔｅｎｏｆｏｖｉｒ）亞拉芬醯胺（ａｌａｆｅｎａｍｉｄｅ）之半反式丁烯二酸鹽
WO2013116720A1 (en) * 2012-02-03 2013-08-08 Gilead Sciences, Inc. Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
US20160184332A1 (en) * 2013-08-14 2016-06-30 Ratiopharm Gmbh Medicament comprising a pharmaceutical combination of drugs
CZ2013985A3 (cs) * 2013-12-09 2015-06-17 Zentiva, K.S. Stabilní farmaceutická kompozice obsahující tenofovir disoproxil fumarát
NO2717902T3 (sl) * 2014-06-20 2018-06-23

Also Published As

Publication number Publication date
KR102313668B1 (ko) 2021-10-19
MA50541A (fr) 2021-04-07
PH12017502431A1 (en) 2018-07-02
JP6667556B2 (ja) 2020-03-18
CL2017003320A1 (es) 2018-07-13
EA201792592A1 (ru) 2018-06-29
IL256364A (en) 2018-02-28
CO2017013293A2 (es) 2018-05-31
MX2017016806A (es) 2018-05-07
JP2021185188A (ja) 2021-12-09
CU20170168A7 (es) 2018-07-05
EP3607939B1 (en) 2022-06-01
JP6978534B2 (ja) 2021-12-08
PT4070788T (pt) 2023-06-06
PE20180411A1 (es) 2018-03-01
EP4233846A3 (en) 2023-10-04
PL4070787T3 (pl) 2023-07-24
ES2945896T3 (es) 2023-07-10
HK1248547A1 (zh) 2018-10-19
JP2020079304A (ja) 2020-05-28
PL3607939T3 (pl) 2022-11-07
PT4070787T (pt) 2023-05-22
SI4070787T1 (sl) 2023-07-31
AU2016287500B2 (en) 2019-05-02
SI3316868T1 (sl) 2020-04-30
JP2018519297A (ja) 2018-07-19
AU2016287500A1 (en) 2018-01-18
CA2990210C (en) 2021-01-12
EP4070787A1 (en) 2022-10-12
KR20200067937A (ko) 2020-06-12
AU2021202009A1 (en) 2021-04-29
EP3316868A1 (en) 2018-05-09
AU2021202009B2 (en) 2023-04-13
PL3316868T3 (pl) 2020-10-19
EP4070788A1 (en) 2022-10-12
AU2019210558A1 (en) 2019-08-15
ES2945345T3 (es) 2023-06-30
CN107847450A (zh) 2018-03-27
AU2019210558B2 (en) 2021-04-22
ES2925246T3 (es) 2022-10-14
ECSP17084331A (es) 2018-01-31
EP3607939A1 (en) 2020-02-12
DOP2017000306A (es) 2018-01-15
CA2990210A1 (en) 2017-01-05
EP3316868B1 (en) 2020-02-19
BR112017027843A2 (pt) 2018-09-04
US20180177734A1 (en) 2018-06-28
EP4233846A2 (en) 2023-08-30
US20170000807A1 (en) 2017-01-05
WO2017004244A1 (en) 2017-01-05
PT3607939T (pt) 2022-09-12
EP4070788B1 (en) 2023-03-22
KR102121329B1 (ko) 2020-06-17
ES2786549T3 (es) 2020-10-13
KR20180021134A (ko) 2018-02-28
SV2017005601A (es) 2018-05-04
EP4070787B1 (en) 2023-03-01
SI3607939T1 (sl) 2022-10-28
PT3316868T (pt) 2020-04-21
PL4070788T3 (pl) 2023-07-10

Similar Documents

Publication Publication Date Title
IL246978A0 (en) New paracetamol formulations
PL4070787T3 (pl) Formulacje farmaceutyczne
HK1254343A1 (zh) 藥物製劑
ZA201903101B (en) Pharmaceutical formulations
IL262745A (en) Improved preparations containing drugs
HK1245653A1 (zh) 藥物製劑
IL253177B (en) Pharmacy preparation
ZA201707094B (en) Pharmaceutical formulations
EP3383371C0 (en) PHARMACEUTICAL FORMULATION
EP3337463A4 (en) PHARMACEUTICAL FORMULATIONS
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (zh) 藥物組合物
GB201520862D0 (en) Pharmaceutical composition
GB201506755D0 (en) Novel pharmaceutical formulation
GB201511246D0 (en) Pharmaceutical formulation
IL271908A (en) Over-compressed pharmaceutical preparations
GB201417589D0 (en) Pharmaceutical Formulations
GB201610440D0 (en) Pharmaceutical formulations
PL3319596T3 (pl) Farmaceutyczne kompozycje
GB201521456D0 (en) Pharmaceutical composition
GB201506598D0 (en) Pharmaceutical compositions
GB201507784D0 (en) Formulations
GB201505532D0 (en) Formulations